surmount-1 tirzepatide weight loss results Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: from the Phase 3 SURMOUNT-2 Trial | Diabetes Therapy Tirzepatide for maintenance of bodyweight
Description
As for side effects, some patients experience bloating, fullness, constipation, and nausea as side effects with either of these products
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
This is because they only work temporarily, and results vary
For weight management, many users require indefinite therapy to maintain weight loss
That is up from 3.5% a year earlier, in 2023, and 1% at the start of 2021
Changing your injection day You can change your weekly injection day as long as there are at least 72 hours (3 days) between doses
